Hematology and Medical Oncology (IM)
Specialty
Specialty Training
| Academic year | 2024 |
| Number of accredited programs | 194 |
| Length of accredited training | 3 |
| Minimum number of prior years required | 3 |
| Offers graduate year 1 positions, available immediately upon medical school completion | no |
| Average number of PY1 interviews | 43.1 |
| Percent of programs requiring Step 1 score for interview | 22% |
| Percent of programs requiring Level 1 score (for DOs) for interview | 62% |
| Total number of active residents/fellows | 2,224 |
| Average number of residents/fellows | 12.4 |
| Average percent female | 46% |
| Average percent international medical graduates | 37% |
| Average percent DOs | 8% |
| Average number of full-time physician faculty | 28.7 |
| Average number of part-time physician faculty | 0.9 |
| Average percent female full-time physician faculty | 41% |
| Average ratio of full-time physician faculty to resident/fellow | 2 |
| Average hours on duty per week | 53 |
| Average maximum consecutive hours on duty | 14 |
| Average days off duty per week | 1.4 |
| Average percent of training in hospital outpatient clinics | 46% |
| Average percent of training in non-hospital ambulatory care community settings | 14% |
| Average resident/fellow compensation | $76,401.47 |
| Average number of days of vacation | 20 |
Graduates' Career Plans
In 2024, 661 residents or fellows completed training in Hematology and Medical Oncology (IM). Program directors knew of the plans of 595 (90%). Please interpret the following accordingly.
| Completing training | 661 |
| With known plans | 595 (90%) |
| Pursuing more training | 16 (2.7%) |
| Practicing in the US | 177 (29.7%) |
| Group practice | 106 (59.9%) |
| In same specialty | 177 (100%) |
| In same state as program | 70 (39.5%) |
| In NHSC or similar underserved area | 6 (3.4%) |
| Academician | 392 (65.9%) |
| Full-time | 388 (99%) |
| Military | 0 (0%) |
| Non-clinical research | 9 (1.5%) |
| Non-medical career/left country | 0 (0%) |
| Unemployed | 1 (0.2%) |